Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Baudin · SciRah

Researcher profile · Semantic Scholar

E. Baudin

Share profile

E. Baudin — researcher profile on SciRah

h-index: 98
Works: 433
Citations: 43K

Most-cited papers

Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
E. Baudin, M. Caplin, R. García-Carbonero, N. Fazio +13 more
2021Annals of Oncology245 citations Open access
Semantic Scholar
Consensus on Molecular Imaging and Theranostics in Neuroendocrine Neoplasms
V. Ambrosini, J. Kunikowska, E. Baudin, L. Bodei +27 more
2021European Journal of Cancer207 citations Open access
Semantic Scholar
MANAGEMENT OF ENDOCRINE DISEASE: Cushing's syndrome due to ectopic ACTH secretion: an expert operational opinion.
J. Young, M. Haissaguerre, Oceana Viera-Pinto, O. Chabre +2 more
2020European Journal of Endocrinology188 citations
Semantic Scholar
Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial
O. Mir, M. Ferrua, A. Fourcade, D. Mathivon +17 more
2022Nature Medicine138 citations Open access
Semantic Scholar
International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers
L. Amar, K. Pacak, O. Steichen, S. Akker +26 more
2021Nature Reviews Endocrinology135 citations Open access
Semantic Scholar
Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).
L. de Mestier, C. Lepage, E. Baudin, R. Coriat +15 more
2020Digestive and Liver Disease127 citations
Semantic Scholar
Anaplastic Thyroid Carcinoma: An Update
A. Jannin, A. Escande, A. Al Ghuzlan, P. Blanchard +9 more
2022Cancers122 citations Open access
Semantic Scholar
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study
J. Strosberg, P. Kunz, A. Hendifar, James C. Yao +42 more
2020European Journal of Nuclear Medicine and Molecular Imaging110 citations Open access
Semantic Scholar
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma
Bin Xu, T. Fuchs, S. Ahmadi, Mohammed I. Alghamdi +23 more
2021Journal of Clinical Oncology107 citations Open access
Semantic Scholar
Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors.
Patrick Robelin, J. Hadoux, J. Forestier, D. Planchard +9 more
2019Journal of Thoracic Oncology65 citations Open access
Semantic Scholar
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study
M. Terzolo, M. Fassnacht, P. Perotti, R. Libé +40 more
2023The Lancet Diabetes and Endocrinology64 citations Open access
Semantic Scholar
Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors
C. Dromain, Marianne Pavel, P. Ruszniewski, Alison Langley +56 more
2019BMC Cancer59 citations Open access
Semantic Scholar
Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France
Alexandre Dormoy, M. Haissaguerre, G. Vitellius, Christine Do Cao +19 more
2022Journal of Clinical Endocrinology and Metabolism52 citations Open access
Semantic Scholar
Redifferentiation of a BRAFK601E -Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib Treatment
S. Leboulleux, C. Dupuy, L. Lacroix, M. Attard +11 more
2019Thyroid52 citations
Semantic Scholar
887O First multicentric randomized phase II trial investigating the antitumor efficacy of peptide receptor radionucleide therapy with 177Lutetium-Octreotate (OCLU) in unresectable progressive neuroendocrine pancreatic tumor: Results of the OCLURANDOM trial
E. Baudin, T. Walter, A. Béron, D. Smith +16 more
2022Annals of Oncology49 citations Open access
Semantic Scholar
Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France.
A. Moya-Plana, A. Aupérin, R. Obongo, A. Baglin +111 more
2019European Journal of Cancer49 citations
Semantic Scholar
Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies
A. Hollebecque, S. Salvagni, R. Plummer, P. Niccoli +16 more
2022Cancer42 citations Open access
Semantic Scholar
Long-term follow-up and safety of vandetanib for advanced medullary thyroid cancer
H. Ramos, Fábio Hecht, A. Berdelou, I. Borget +3 more
2020Endocrine35 citations
Semantic Scholar
Can preoperative ultrasound predict extrathyroidal extension of differentiated thyroid cancer?
L. Lamartina, S. Bidault, J. Hadoux, J. Guerlain +8 more
2021European Journal of Endocrinology34 citations Open access
Semantic Scholar
Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases.
L. Dahan, R. Giorgi, S. Vergez, L. Le Taillandier de Gabory +129 more
2020European Journal of Surgical Oncology34 citations Open access
Semantic Scholar
Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma
A. Hollebecque, S. Salvagni, R. Plummer, N. Isambert +17 more
2020Clinical Cancer Research34 citations Open access
Semantic Scholar
Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer
D. Hartl, J. Guerlain, I. Breuskin, J. Hadoux +5 more
2020Cancers34 citations Open access
Semantic Scholar
Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms.
M. Rubino, J. Scoazec, E. Pisa, M. Faron +11 more
2020Lung Cancer32 citations
Semantic Scholar
Differentiated Thyroid Cancer in Children and Adolescents: Long Term Outcome and Risk Factors for Persistent Disease
Giulia Sapuppo, D. Hartl, B. Fresneau, J. Hadoux +8 more
2021Cancers29 citations Open access
Semantic Scholar
Strategies for Radioiodine Treatment: What’s New
C. Sparano, S. Moog, J. Hadoux, C. Dupuy +6 more
2022Cancers28 citations Open access
Semantic Scholar
Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric Experience
C. Touloupas, M. Faron, J. Hadoux, F. Deschamps +14 more
2021Cancers28 citations Open access
Semantic Scholar
Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data.
A. Boilève, M. Faron, S. Fodil-Cherif, A. Bayle +9 more
2023European Journal of Cancer27 citations Open access
Semantic Scholar
567O First International Randomized Study in Malignant Progressive Pheochromocytoma and Paragangliomas (FIRSTMAPPP): An academic double-blind trial investigating sunitinib
E. Baudin, B. Goichot, A. Berruti, J. Hadoux +16 more
2021Annals of Oncology27 citations Open access
Semantic Scholar
Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival
A. Jannin, L. Lamartina, C. Moutarde, M. Djennaoui +9 more
2022European Journal of Nuclear Medicine and Molecular Imaging24 citations Open access
Semantic Scholar
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network.
J. Hadoux, C. Kanaan, A. Durand, S. Hescot +21 more
2021European Journal of Cancer23 citations Open access
Semantic Scholar
Intervention combining nurse navigators (NNs) and a mobile application versus standard of care (SOC) in cancer patients (pts) treated with oral anticancer agents (OAA): Results of CapRI, a single-center, randomized phase III trial.
O. Mir, M. Ferrua, A. Fourcade, D. Mathivon +16 more
202022 citations
Semantic Scholar
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question
V. Basile, S. Puglisi, B. Altieri, L. Canu +18 more
2021Journal of Personalized Medicine21 citations Open access
Semantic Scholar
1096O Lanreotide autogel/depot (LAN) in patients with advanced bronchopulmonary (BP) neuroendocrine tumors (NETs): Results from the phase III SPINET study
E. Baudin, D. Hörsch, S. Singh, M. Caplin +10 more
2021Annals of Oncology21 citations Open access
Semantic Scholar
Succinate: a serum biomarker of SDHB mutated paragangliomas and pheochromocytomas.
C. Lamy, H. Tissot, M. Faron, E. Baudin +8 more
2022Journal of Clinical Endocrinology and Metabolism20 citations Open access
Semantic Scholar
Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients
M. Terzolo, M. Fassnacht, P. Perotti, R. Libé +20 more
2021Journal of the Endocrine Society19 citations Open access
Semantic Scholar
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors
P. Girot, E. Baudin, H. Sénellart, N. Bouarioua +14 more
2021Neuroendocrinology19 citations Open access
Semantic Scholar
FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin.
J. Hadoux, P. Afchain, T. Walter, D. Tougeron +8 more
2021Digestive and Liver Disease19 citations Open access
Semantic Scholar
Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC
Mabrouka Doghman-Bouguerra, P. Finetti, Nelly Durand, I. Z. Parise +17 more
2020Cancers17 citations Open access
Semantic Scholar
Locally unresectable differentiated thyroid cancer: outcomes and perspectives
L. Lamartina, Y. Godbert, C. Nascimento, Do C. Cao +13 more
2020Endocrine17 citations
Semantic Scholar
Recurrence-free survival analysis in locally advanced pheochromocytoma: first appraisal.
S. Moog, F. Castinetti, C. Docao, L. Amar +22 more
2021Journal of Clinical Endocrinology and Metabolism16 citations Open access
Semantic Scholar
Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era
V. Rodríguez-Freixinós, J. Capdevila, M. Pavel, A. Thawer +13 more
2020European Journal of Cancer16 citations Open access
Semantic Scholar
Surgery in the context of kinase inhibitor therapy for locally invasive thyroid cancer.
D. Hartl, J. Guerlain, Ingrid Bresuskin, E. Baudin +4 more
2020European Journal of Surgical Oncology15 citations
Semantic Scholar
Prognostic of recurrence and survival in poorly differentiated thyroid cancer.
S. Hescot, A. Al Ghuzlan, T. Henry, Hala Sheikh Alard +10 more
2022Endocrine-Related Cancer14 citations
Semantic Scholar
Combination of mitotane and locoregional treatments in low-volume metastatic adrenocortical carcinoma.
A. Boilève, E. Mathy, Charles Roux, M. Faron +9 more
2021Journal of Clinical Endocrinology and Metabolism13 citations
Semantic Scholar
Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice
V. Prasad, R. Srirajaskanthan, C. Toumpanakis, C. Grana +10 more
2020European Journal of Nuclear Medicine and Molecular Imaging13 citations Open access
Semantic Scholar
First multicentric randomized phase II trial investigating the antitumor efficacy of peptide receptor radionuclide therapy with 177Lutetium – Octreotate (OCLU) in unresectable progressive neuroendocrine pancreatic tumor: Results of the OCLURANDOM trial, on behalf of the ENDOCAN RENATEN network and G
E. Baudin, T. Walter, C. Docao, M. Haissaguerre +8 more
2022Annales d'Endocrinologie12 citations
Semantic Scholar
Impact of lymphovascular invasion on otherwise low-risk papillary thyroid carcinomas: a retrospective and observational study
F. Puga, A. Al Ghuzlan, Dana M. Hartl, M. Bani +9 more
2023Endocrine11 citations Open access
Semantic Scholar
Risk staging with prophylactic unilateral central neck dissection in low-risk papillary thyroid carcinoma.
D. Hartl, A. Al Ghuzlan, S. Bidault, I. Breuskin +5 more
2022European Journal of Surgical Oncology11 citations Open access
Semantic Scholar
ENSAT Registry-Based Randomized Clinical Trials for Adrenocortical Carcinoma.
J. Crona, E. Baudin, M. Terzolo, A. Chrisoulidou +47 more
2020European Journal of Endocrinology11 citations Open access
Semantic Scholar
Loco-Regional Therapies in Oligometastatic Adrenocortical Carcinoma
Charles Roux, A. Boilève, M. Faron, L. Lamartina +8 more
2022Cancers10 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Hadoux×24
Invite
J. Hadoux — researcher profile on SciRah
L. Lamartina×18
Invite
L. Lamartina — researcher profile on SciRah
A. Al Ghuzlan×15
Invite
A. Al Ghuzlan — researcher profile on SciRah
S. Leboulleux×14
Invite
S. Leboulleux — researcher profile on SciRah

×9

Invite

M. Faron — researcher profile on SciRah

M. Fassnacht×7

Invite

M. Fassnacht — researcher profile on SciRah

Invite

T. Walter — researcher profile on SciRah

M. Schlumberger×7

Invite

M. Schlumberger — researcher profile on SciRah

Invite

J. Guerlain — researcher profile on SciRah

Invite

S. Hescot — researcher profile on SciRah

Invite

A. Berruti — researcher profile on SciRah

J. Capdevila×6

Invite

J. Capdevila — researcher profile on SciRah